Billionaires Are Buying Hims & Hers Health Hand Over Fist. Should You Follow Their Lead?
Sales growth could accelerate now that it provides lower-cost, weight-management drugs.
| Ticker |
Sentiment |
Impact |
|
HIMS
|
Somewhat Bullish
|
21 %
|
|
NVO
|
Neutral
|
11 %
|
|
UNH
|
Neutral
|
5 %
|
